NEW YORK--(BUSINESS WIRE)--General American Investors Company, Inc., a closed-end investment company listed on the New York Stock Exchange (GAM), filed with the U.S. Securities and Exchange Commission (SEC) its Certified Shareholder Report (Form N-CSR) for the six month period ended June 30, 2015. The Form N-CSR contains the Company’s June 30, 2015 Semi-Annual Report and is available at the SEC’s website: www.sec.gov and the Company’s website: www.generalamericaninvestors.com. The Semi-Annual Report is expected to be mailed to stockholders shortly.
The Semi-Annual Report indicates that as of or for the six months ended:
|Net Assets Applicable to Common Stock||$1,205,272,616||$1,282,274,345|
|Net Assets Per Common Share||$40.72*||$43.45|
|Net Investment Income||$7,263,861||$4,746,905|
|Net Gain on Investments||$20,437,152||$68,554,571|
|Common Shares Outstanding||29,602,413||29,513,265|
* After dividends and distributions of $3.50 per share paid in December 2014.
Securities Transactions and Positions
The Company reported that it made new commitments during the second quarter of 2015 in Paratek Pharmaceuticals and Verint Systems, and increased its holdings in Anadarko Petroleum, Cameco, Danone, Huntsman, Repros Therapeutics, and Synchronoss Technologies.
The Company’s position in The Dow Chemical Company was eliminated, while reductions were made in the holdings of ASML Holding N.V., Ciena, FCB Financial Holdings, Gilead Sciences, JPMorgan Chase, Nelnet, Owens Corning, Pfizer, and Towers Watson.
The largest stock holdings in the Company’s portfolio at June 30, 2015 included: The TJX Companies, Gilead Sciences, Apple, Arch Capital Group Ltd., and Costco Wholesale Corp.